Transcat, Inc. (NASDAQ:TRNS) Given Average Recommendation of “Hold” by Brokerages

Shares of Transcat, Inc. (NASDAQ:TRNS) have earned a consensus recommendation of “Hold” from the five brokerages that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $111.50.

Several analysts have recently commented on TRNS shares. Craig Hallum increased their target price on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. Oppenheimer cut Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 29th. HC Wainwright decreased their price target on Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. Finally, Northland Securities reiterated a “market perform” rating and issued a $85.00 price target (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th.

Insider Activity at Transcat

In related news, Director Craig D. Cairns bought 1,200 shares of Transcat stock in a transaction on Friday, January 31st. The shares were purchased at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the completion of the acquisition, the director now owns 1,910 shares in the company, valued at approximately $147,108.20. This represents a 169.01 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 2.30% of the stock is owned by company insiders.

Hedge Funds Weigh In On Transcat

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TRNS. T. Rowe Price Investment Management Inc. boosted its holdings in Transcat by 178.0% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 518,597 shares of the scientific and technical instruments company’s stock worth $54,837,000 after buying an additional 332,064 shares during the last quarter. Champlain Investment Partners LLC boosted its holdings in Transcat by 35.7% during the fourth quarter. Champlain Investment Partners LLC now owns 555,650 shares of the scientific and technical instruments company’s stock worth $58,754,000 after buying an additional 146,150 shares during the last quarter. Conestoga Capital Advisors LLC boosted its holdings in Transcat by 17.9% during the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after buying an additional 137,830 shares during the last quarter. Royal Bank of Canada boosted its holdings in Transcat by 328.4% during the fourth quarter. Royal Bank of Canada now owns 173,514 shares of the scientific and technical instruments company’s stock worth $18,348,000 after buying an additional 133,013 shares during the last quarter. Finally, Granahan Investment Management LLC boosted its holdings in Transcat by 132.0% during the fourth quarter. Granahan Investment Management LLC now owns 188,763 shares of the scientific and technical instruments company’s stock worth $19,960,000 after buying an additional 107,389 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.

Transcat Stock Performance

Transcat stock opened at $79.52 on Friday. The stock has a fifty day moving average price of $93.04 and a two-hundred day moving average price of $107.90. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The firm has a market capitalization of $740.25 million, a P/E ratio of 42.98 and a beta of 0.67. Transcat has a 52-week low of $73.37 and a 52-week high of $147.12.

Transcat (NASDAQ:TRNS) last announced its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter in the previous year, the firm earned $0.56 EPS. As a group, analysts anticipate that Transcat will post 2.3 EPS for the current fiscal year.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.